Magic mushroom therapy targets Cancer-Related anxiety in new trial
Symptom relief
Recruiting now
This study tests whether a single dose of NPX-5 (a psilocybin drug) combined with talk therapy can reduce severe anxiety in people who have trouble adjusting to a cancer diagnosis. About 87 adults aged 18–80 with moderate-to-severe anxiety will receive one of three doses (25 mg, …
Phase: PHASE2 • Sponsor: Psyence Australia Pty Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC